-
Asín-Prieto E, Rodríguez-Gascón A, Trocóniz IF, Soraluce A, Maynar J, Sánchez-Izquierdo JA, Isla A.
Population pharmacokientics of piperacillin and tazobactam in critically ill patients undergoing continous renal replacment therapy: application to pharmacokinetic/pharmacodynamic analysis
Journal of Antimicrobial and Chemotherapy,
2014;
69,
180 - 189
-
Calvo B. Author's Reply to Borg et al
Comment on: EU's New Pharmacovigilance Legislation: Considerations for Biosimilars
Drug Safety,
2014;
37,
125 - 126
-
Calvo B, Zuñiga L.
EU's New Pharmacovigilance Legislation: Considerations for Biosimilars
Drug Safety,
2014;
37,
9 - 18
-
Beloqui A, Solinís MA, Delgado A, Évora C, Isla A, Rodríguez-Gascón A.
Fate of Nanostructured Lipid Carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution
Journal of Microencapulation,
2014;
31,
1 - 8
-
Torrecilla J, Rodríguez-Gascón A, Solinís MÁ, del Pozo-Rodríguez A
Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives
BioMed Research International,
2014;
2014
-
Rodríguez-Gascón A, del Pozo-Rodríguez A, Solinís MÁ
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.
International Journal of Nanomedicine,
2014;
9,
1833 - 1843
-
Beloqui A, Solinís MÁ, des Rieux A, Préat V, Rodríguez-Gascón A.
Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
International Journal of Pharmaceutics,
2014;
468,
105 - 111
-
Lertxundi U, Domingo-Echaburu S, Irigoyen I, Isla A, Solinís MA, García-Moncó JC
Desafíos en el manejo farmacoterapéutico del paciente ingresado con enfermedad de Parkinson
Revista de Neurología,
2014;
58,
353 - 364
